| 2015 | | A composition for treating diseases related to angiogenesis and cornea or conjunctiva transplant using chondrocyte-derived extracellular matrix membrane | 민병현, 최병현 |
| - | | A novel stem cell source derived from fetal cartilage tissue and cellular therapeutic agent | 민병현, 최병현 |
| - | | Adverse Dug Events Surveillance System | 박래웅, 박만영, 최종필 |
| 2018 | | Biomarker composition for diagnosing cancer with mitochondrial dysfunction and method for diagnosing cancer using the same marker | 우현구, 윤계순, 이영경 |
| 2017 | | Biomarker composition for diagnosing cancer with mitochondrial dysfunction comprising NUPR1 and method for diagnosing cancer using the same marker | 우현구, 윤계순, 이영경 |
| - | | Biomarker composition for diagnosing cell senescence comprising UHRF1 and DNMT1 | 변해옥, 윤계순, 이영경 |
| 2022 | | Biomarker composition for diagnosing diffuse type gastric cancer and medical use thereof | 함인혜, 허훈 |
| 2018 | | Biomarker Composition for Diagnosing Nanoparticles Neurotoxicity by Increasing Cytoplasmic Inclusion Bodies in vitro | 백만정, 신태환, 이광 |
| 2014 | | Biomarker Composition for Diagnosis of Nanoparticles Toxicity | 백만정, 이광 |
| 2018 | | Biomarker composition for predicting prognosis of gastric cancer | 박시형, 우현구 |
| 2019 | | Biomarkers composition for detecting damage of cell and uses thereof | 백만정, 신태환, 이광 |
| 2021 | | Cell culture bioreactor containing cellulosose membrane | 민병현, 박인수 |
| 2018 | | COMPOSITION FOR CARTILAGE REGENERATION AND PREPARING THEREOF | 김영직, 민병현, 최병현 |
| 2016 | | Composition for preventing of adhesion comprising surface-modified chondrocyte-derived extracellular matrix membrane | 민병현, 최병현 |
| - | | Composition for treating articular cartilage repair | 민병현, 최병현 |
| - | | Composition for treatment of cartilage damage and method for preparation of artificial cartilage | 김영직, 민병현, 최병현 |
| 2017 | | Composition for treatment of cartilage damage and method for preparation of artificial cartilage | 김영직, 민병현, 최병현 |
| 2019 | | DEVICE FOR SUPPORTING HOOP STRESS OF MENISCUS | 김영직, 민병현, 박도영 |
| 2014 | | Evaluation Method of Toxicity of Nanoparticles | 백만정, 이광 |
| 2015 | | Kit and method for diagnosis of cell senescence | 김유미, 변해옥, 우현구, 윤계순 |
| 2019 | | Method for adjusting degradation rate of animal cartilage-derived extracellular matrix membrane and animal cartilage-derived extracellular matrix membrane having adjustable degradation rate by using the same | 김영직, 민병현 |
| 2021 | | Method for differentiation of hepatocyte derived from human adipose-derived stem cells and Hepatocyte | 박인수 |
| - | | Method for increasing yield of biological nanoparticle | 민병현, 최병현 |
| 2007 | | Method for Preparing a Cell―Derived ExtracellularMatrix Scaffold | 민병현, 박귀덕 |
| 2017 | | Method for preparing biocompatible porcine cartilage-derived extracellular matrix membrane having adjustable in vivo degradation rate and mechanical property and composition to prevent the adhesion between tissues and/or organs | 김영직, 민병현 |
| - | | METHOD FOR PREPARING HYDROGEL FOR PREVENTING SURGICAL ADHESIONS, HYDROGEL, FILM AND POROUS MATERIAL USING THE SAME | 김영직, 민병현 |
| 2012 | | Method for simultaneous analysis of melatonin and its precursor by using gas chromatography-mass spectrometry | 백만정, 안영환, 이광 |
| 2021 | | Micro needle stamping machine for chemical solution injection | 박인수 |
| 2021 | | Optical therapy device using ultrasound and bubble generating material injection device | 박인수 |
| 2008 | | Peptides that improve a resistance in myoblasts | 우주홍 |
| 2017 | | Screening Method of therapeutic agents for cancer with mitochondrial dysfunction by regulation of Claudin-1 expression | 윤계순, 이영경 |
| - | | siRNA for inhibiting IL-6 expression and compositioncontaining them | 변해옥, 손성향 |
| - | | The pharmaceutical composition for wound healing comprising conditioned medium containing cell spheroid derived from adipose-derived stem cell | 박인수 |
| - | | Tissue consolidant composition with increased adhesion and binding force to biological tissues and preparing method thereof | 민병현, 박인수 |
